November 08, 2007

Short Summaries of News Relating to Schizophrenia

Following is a quick list of interesting news relating to schizophrenia and mental health in general:

  • One of the Top 10 Neuroscience Trends of 2007 is that the field of study called Neuroimmunology is leading to new treatment targets - and this suggests that the future is looking better for people who have schizophrenia. The discovery that immune molecules play a crucial role in shaping neuronal connections opens up new treatment targets for Alzheimer’s, autism, ALS, Parkinson’s, schizophrenia, and nerve injury.
  • We've covered in our report on smoking and schizophrenia - that there is research that suggests that there are some benefits experienced by people with mental illness who use nicotine, now a new study suggests that nicotine might not be beneficial to schizophrenia related symptoms after all.
  • The Norwegian early treatment center for schizophrenia and psychosis has recently updated their web site with some good articles on early treatment, and the benefits that people gain from it. Check it out here: TIPS program website
  • The LA Times has an in-depth and important article entitled 'Are we too quick to medicate children?'
  • The ten-day Rendezvous with Madness Film Festival began Thursday in Canada. The festival, currently in its 15th year, shows new and "ground breaking" films on mental illness. Read more about the festival.
  • According to a new story, recent research findings continue to support past research which demonstrates the positive effect good physical health has on mental health. Read the story about a woman who started exercising to combat her depression and is now co-leader of an exercise group that began as an effort to prevent early death in those suffering from mental illness.
  • Researchers have found a different biological framework for representing schizophrenia, one that might aid their general understanding and treating of the illness.
  • (This is only for the biology-enthusiasts in the audience)


    Comments

    Post a comment

    Please enter this code to enable your comment -
    Remember Me?
    (you may use HTML tags for style)
    * indicates required
    Close